These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 32583237)

  • 1. Melatonin: an endogenous miraculous indolamine, fights against cancer progression.
    Samanta S
    J Cancer Res Clin Oncol; 2020 Aug; 146(8):1893-1922. PubMed ID: 32583237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MT1 and MT2 Melatonin Receptors: A Therapeutic Perspective.
    Liu J; Clough SJ; Hutchinson AJ; Adamah-Biassi EB; Popovska-Gorevski M; Dubocovich ML
    Annu Rev Pharmacol Toxicol; 2016; 56():361-83. PubMed ID: 26514204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic actions of melatonin in cancer: possible mechanisms.
    Srinivasan V; Spence DW; Pandi-Perumal SR; Trakht I; Cardinali DP
    Integr Cancer Ther; 2008 Sep; 7(3):189-203. PubMed ID: 18815150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that membrane-bound G protein-coupled melatonin receptors MT1 and MT2 are not involved in the neuroprotective effects of melatonin in focal cerebral ischemia.
    Kilic U; Yilmaz B; Ugur M; Yüksel A; Reiter RJ; Hermann DM; Kilic E
    J Pineal Res; 2012 Mar; 52(2):228-35. PubMed ID: 21913972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [MT1 melatonin receptors and their role in the oncostatic action of melatonin].
    Danielczyk K; Dziegiel P
    Postepy Hig Med Dosw (Online); 2009 Sep; 63():425-34. PubMed ID: 19837985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melatonin: A Potential Antineoplastic Agent in Breast Cancer.
    Samanta S
    J Environ Pathol Toxicol Oncol; 2022; 41(4):55-84. PubMed ID: 36374962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melatonin protects against cisplatin-induced ovarian damage in mice via the MT1 receptor and antioxidant activity.
    Barberino RS; Menezes VG; Ribeiro AEAS; Palheta RC; Jiang X; Smitz JEJ; Matos MHT
    Biol Reprod; 2017 Jun; 96(6):1244-1255. PubMed ID: 28595266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin MT
    López-Canul M; Min SH; Posa L; De Gregorio D; Bedini A; Spadoni G; Gobbi G; Comai S
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31108968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of melatonin receptors MT1 and MT2 in the hypothalamic suprachiasmatic nucleus during depression.
    Wu YH; Ursinus J; Zhou JN; Scheer FA; Ai-Min B; Jockers R; van Heerikhuize J; Swaab DF
    J Affect Disord; 2013 Jun; 148(2-3):357-67. PubMed ID: 23357659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The endogenous melatonin (MT) signal facilitates reentrainment of the circadian system to light-induced phase advances by acting upon MT2 receptors.
    Pfeffer M; Rauch A; Korf HW; von Gall C
    Chronobiol Int; 2012 May; 29(4):415-29. PubMed ID: 22489607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncostatic activities of melatonin: Roles in cell cycle, apoptosis, and autophagy.
    Targhazeh N; Reiter RJ; Rahimi M; Qujeq D; Yousefi T; Shahavi MH; Mir SM
    Biochimie; 2022 Nov; 202():34-48. PubMed ID: 35752221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracoronary melatonin increases coronary blood flow and cardiac function through β-adrenoreceptors, MT1/MT2 receptors, and nitric oxide in anesthetized pigs.
    Grossini E; Molinari C; Uberti F; Mary DA; Vacca G; Caimmi PP
    J Pineal Res; 2011 Sep; 51(2):246-57. PubMed ID: 21545522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin in cardiovascular disease.
    Dominguez-Rodriguez A
    Expert Opin Investig Drugs; 2012 Nov; 21(11):1593-6. PubMed ID: 22916801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional MT1 and MT2 melatonin receptors in mammals.
    Dubocovich ML; Markowska M
    Endocrine; 2005 Jul; 27(2):101-10. PubMed ID: 16217123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melatonin in the mammalian retina: Synthesis, mechanisms of action and neuroprotection.
    Felder-Schmittbuhl MP; Hicks D; Ribelayga CP; Tosini G
    J Pineal Res; 2024 Apr; 76(3):e12951. PubMed ID: 38572848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perioperative melatonin use.
    Jarratt J
    Anaesth Intensive Care; 2011 Mar; 39(2):171-81. PubMed ID: 21485664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photoperiodic regulation of MT1 and MT2 melatonin receptor expression in spleen and thymus of a tropical rodent Funambulus pennanti during reproductively active and inactive phases.
    Ahmad R; Haldar C
    Chronobiol Int; 2010 May; 27(3):446-62. PubMed ID: 20524795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin receptors in diabetes: a potential new therapeutical target?
    She M; Laudon M; Yin W
    Eur J Pharmacol; 2014 Dec; 744():220-3. PubMed ID: 25160745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin receptors as therapeutic targets in the suprachiasmatic nucleus.
    Pévet P
    Expert Opin Ther Targets; 2016 Oct; 20(10):1209-18. PubMed ID: 27082492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the daily changes of melatonin receptors in the rat liver.
    Venegas C; García JA; Doerrier C; Volt H; Escames G; López LC; Reiter RJ; Acuña-Castroviejo D
    J Pineal Res; 2013 Apr; 54(3):313-21. PubMed ID: 23110416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.